Explore 3 Stock Ideas & Industry Insights Download Free Report

NetraMark Holdings Inc.

Company price
0.3498 USD 0.00(0%)
Last update at 2026-11-19T21:00:00Z
VOLUME
2500
Market Cap
37.71M

Momentum Score

…

NetraMark Holdings Inc. provides AI-powered insights and software solutions to trial sponsors, clinical research organizations, and biotechnology companies worldwide. It operates NetraAI platform, an advanced machine learning system purpose-built for analyzing complex clinical trial data to identify meaningful patient subpopulations. The company was formerly known as Nurosene Health Inc. and changed its name to NetraMark Holdings Inc. in February 2023. NetraMark Holdings Inc. was founded in 2016 and is headquartered in Toronto, Canada.

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Day Price Range
0.35
Low
0.35
High
52 Week Price Range
0.40
Low
1.15
High

Momentum Score

…
Loading momentum score…

A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.

Score - Rating
>= 1 - Low / > 1 but < 2 - Below Average / > 2 but < 3 - Average / > 3 but < 4 - Above Average / > 4 - High
AI Summary

NetraMark Holdings Inc., quoted on the OTC Pink under ticker AINMF, has limited public information and no verifiable description of its core operations. Long-term growth drivers are unclear and would depend on future audited financials or material business developments. Investors may view the company as a speculative opportunity if management demonstrates credible revenue growth or strategic transactions, though such outcomes remain uncertain.

Material investment risks include very low trading liquidity, potential for significant share dilution, absence of audited financials and limited corporate governance, plus heightened regulatory and financing uncertainty.

Risk Score
High

Note: The summary and risk score provided above is created by AI and should not be construed as a recommendation of Kalkine.

Key Metrics*

Previous Close
0.35
Dividend Yield
-
Revenue TTM
0.61M
Revenue Per Share
0.01
Gross Profit TTM
0.61M
Debt / Equity
-
ROE
-314.71%
Net Debt
-
ROCE
-284.61%
Diluted EPS TTM
-0.05

Key Financials*

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2025-09-30 2024-09-30 2023-09-30 2022-09-30 2021-09-30
Type yearly yearly yearly yearly yearly
Date 2025-09-30 2024-09-30 2023-09-30 2022-09-30 2021-09-30
Income before tax -5.22M -3.33M -14.17M -13.70M -5.08M
Net income -5.22M -3.33M -14.17M -13.45M -5.08M
Selling general administrative 5.70M 3.93M 5.45M 7.45M 5.05M
Reconciled depreciation - 0.00M 0.61M 0.60M -
Ebit - - - -7.40M -5.05M
Ebitda - - - -7.34M -5.05M
Operating income -5.22M -3.33M -5.86M -7.93M -5.05M
Tax provision - - 0.00M -0.25M -
Income tax expense - - - -0.25M -
Total revenue 0.43M 0.46M 0.09M 0.11M 0.00M
Total operating expenses 5.65M 3.79M 5.95M 8.05M 5.05M
Total other income expense net 0.04M 0.14M -8.31M -5.76M -0.04M
Net income from continuing ops -5.22M -3.33M -14.17M -13.45M -5.08M
Net income applicable to common shares - - - -13.45M -5.08M
Breakdown 2025-09-30 2024-09-30 2023-09-30 2022-09-30 2021-09-30
Type yearly yearly yearly yearly yearly
Date 2025-09-30 2024-09-30 2023-09-30 2022-09-30 2021-09-30
Total assets 2.18M 0.21M 1.91M 9.20M 8.40M
Intangible assets - - - 2.52M 1.58M
Total liab 0.34M 0.41M 0.82M 1.09M 0.46M
Total stockholder equity 1.83M -0.20M 1.09M 8.11M 7.94M
Deferred long term liab - - - - 1.58M
Other current liab - - - 0.02M -
Common stock - - - 24.25M 11.75M
Capital stock 39.02M 30.50M 28.82M 24.25M 11.75M
Retained earnings -41.55M -36.33M -32.99M -18.82M -5.38M
Good will - - 0.00M 6.41M -
Other assets - - - - 1.58M
Cash 1.50M 0.06M 1.78M 0.01M 6.29M
Total current liabilities 0.34M 0.41M 0.82M 1.09M 0.46M
Total current assets 2.18M 0.21M 1.91M 0.28M 6.82M
Net tangible assets - - - -0.81M 7.94M
Short term investments 0.53M 0.01M 0.01M 0.01M 0.04M
Net receivables 0.00M 0.08M 0.00M 0.25M 0.35M
Accounts payable - - - 1.06M 0.46M
Non current assets total 0.00M 0.00M 0.00M 8.92M 1.58M
Breakdown 2025-09-30 2024-09-30 2023-09-30 2022-09-30 2021-09-30
Type yearly yearly yearly yearly yearly
Date 2025-09-30 2024-09-30 2023-09-30 2022-09-30 2021-09-30
Investments -0.51M -0.00M 0.00M 0.04M -0.04M
Change to liabilities - - - 0.47M 0.32M
Total cashflows from investing activities - - - -2.19M -1.62M
Total cash from financing activities 5.76M 0.57M 4.16M 0.69M 8.67M
Change to operating activities - - - 0.24M -0.37M
Net income -5.22M -3.33M -14.17M -13.45M -5.08M
Change in cash 1.44M -1.72M 1.77M -6.28M 4.44M
Begin period cash flow 0.06M 1.78M 0.01M 6.29M 1.84M
End period cash flow 1.50M 0.06M 1.78M 0.01M 6.29M
Total cash from operating activities -3.81M -2.29M -2.39M -4.78M -2.60M
Issuance of capital stock - 0.00M 3.97M 0.58M 8.67M
Depreciation - 0.00M 0.61M 0.60M 0.60M
Change to account receivables 0.08M -0.08M 0.01M -0.01M -0.01M
Change to netincome - - - 7.37M 2.53M
Capital expenditures 0.00M 0.00M 0.00M 0.15M 0.00M
Change in working capital -0.07M -0.43M 0.23M 0.70M -1.67M
Stock based compensation 0.82M 0.60M 1.43M 1.25M 1.21M
Other non cash items 0.66M 0.88M 1.31M 0.61M 1.32M
Free cash flow -3.81M -2.29M -2.39M -4.93M -4.23M

Peer Comparison*

Sector: Healthcare Industry: Health Information Services

Stock Name
Change
(USD)
Price
(USD)
Trailing
PE (x)
Forward
PE (x)
Price Sales
TTM (x)
Price to Book Value (x)
Enterprise Value
to Revenue (x)
Enterprise Value
to EBITDA (x)
AINMF
NetraMark Holdings Inc.
-
-%
0.35 - - 62.23 17.52 97.83 -3.60
VEEV
Veeva Systems Inc Class A
-0.05
0.02%
266.22 43.49 29.59 12.48 5.79 10.39 33.41
PMCUF
Pro Medicus Limited
-6.60
5.03%
124.50 64.90 90.91 49.11 38.05 65.12 83.47
TEM
Tempus AI, Inc. Class A Common Stock
-5.60
9.39%
54.01 - - 8.68 25.39 8.33 -
MTHRY
M3 Inc
-0.07
1.31%
5.28 31.84 26.25 0.05 4.60 0.04 0.12

Profile*

NetraMark Holdings Inc.

NetraMark Holdings Inc. provides AI-powered insights and software solutions to trial sponsors, clinical research organizations, and biotechnology companies worldwide. It operates NetraAI platform, an advanced machine learning system purpose-built for analyzing complex clinical trial data to identify meaningful patient subpopulations. The company was formerly known as Nurosene Health Inc. and changed its name to NetraMark Holdings Inc. in February 2023. NetraMark Holdings Inc. was founded in 2016 and is headquartered in Toronto, Canada.

1655 Dupont Street, Toronto, ON, Canada, M6P 3T1

403 681 2549

Name Title Year Born
Mr. George Achilleos President, CEO & Director NA
Dr. Joseph Geraci Ph.D. Founder, Chief Scientific & Technical Officer and Director NA
Mr. Swapan Kakumanu ACA, ACWA, CGA CFO & Corporate Secretary 1970
Mr. Josh Spiegel President of NetraMark Corp NA
Ms. Jaime Hackett Vice President of Marketing NA
Dr. Luca Pani M.D. Chief Innovation & Regulatory Officer and Chief Medical Advisor NA
Dr. Kaveh Kavoosi Head of Progressive Medicine NA
Dr. Larry Alphs Chief Medical Officer & Member of Advisory Board NA
Dr. Angelico Carta M.D. Chief Strategy Officer NA
Dr. Jan Sedway Ph.D. Senior Vice President of Clinical Science NA

Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

Support

Hi! How can we help you today?

Loading…